Lonza will purchase the German Merck’s U.S.-based CDMO network for mid-triple-digit million euros. Besides five sites, the deal will bolster Lonza’s prowess in rapidly growing sectors such as cell and gene therapy, bioconjugates, viral vectors and advanced drug-delivery technologies.
Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business
Latest from Blog
Wildfire Smoke Increasing At Schools And Childcare Centers Nationwide MedNews
TUESDAY, Nov. 3, 2026 Kids across the U.S. are facing more days of wildfire smoke at school.And some buildings are failing to keep potentially dangerous polluti Post Views: 1
Child dies of measles in New York’s first such death in 30 years
LOWVILLE, N.Y. — A child in rural northern New York has died after contracting measles, marking the state’s first death from the disease in 30 years, state officials announced Monday. The child
A Doctor’s Take: When The Diagnosis Isn’t Right: What You Need To Know About Misdiagnosis MedNews
TUESDAY, Nov. 3, 2026 Getting the right diagnosis isn t always easy. Some illnesses develop slowly, some have vague symptoms, and many can be mistaken for somet Post Views: 1
First U.S. bird flu death of the year after cattle exposure
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning and happy election day. At the very least, after today, we can
Sleep Paralysis, Vivid Nightmares Plague Some Users Of Cutting-Edge Insomnia Drug MedNews
TUESDAY, Nov. 3, 2026 Troubling side effects including sleep paralysis and nightmares are causing some people to stop taking a cutting-edge insomnia drug, a new Post Views: 1